Galactooligosaccharide in combination with Bifidobacterium and Bacteroides affects the population of Clostridium perfringens in the intestine of gnotobiotic mice

Nutrition Research

Volumn 22, Issue 11, 2002, Pages 1333-1341

  Morishita, Y ^a   Oowada, T ^a   Ozaki, A ^a   Mizutani, T ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

Bacteroides; Bifidobacterium; Bowel microflora; C. perfringens; Galactooligosaccharide

Indexed keywords

GALACTOSE; OLIGOSACCHARIDE;

ANAEROBIC BACTERIUM; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL GROWTH; BACTEROIDES; BACTEROIDES VULGATUS; BIFIDOBACTERIUM; BIFIDOBACTERIUM BREVE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; DIETARY INTAKE; FOOD COMPOSITION; GERMFREE ANIMAL; INTESTINE FLORA; LACTOBACILLUS SALIVARIUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TIME;

ANIMALIA; BACTERIA (MICROORGANISMS); BACTEROIDES; BACTEROIDES VULGATUS; BIFIDOBACTERIUM; BIFIDOBACTERIUM BREVE; CLOSTRIDIUM; CLOSTRIDIUM PERFRINGENS; LACTOBACILLUS; LACTOBACILLUS SALIVARIUS;

EID: 0036845440     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(02)00455-4     Document Type: Article

References (35)

1. Lundequist B, Nord CE, Winberg J. The composition of faecal microflora in breastfed and bottle-fed infants from birth to eight weeks. Acta Paediatr Scand 1985;74:45-51.
2. Mitsuoka T, Hayakawa K. Die Faekalflora bei Menschen. I. Mitteilung: Die Zusamensetzung der Faekalflora der verschiedenen Altersgruppen. Zbl Bakteriol Hyg I Orig A 1973;233:333-42.
3. Romiti VO, Duerden BI. The development of the bacterial flora in normal neonates. J Med Microbiol 1981;14:51-62.
4. Yoshioka H, Iseki K-I, Fujita F. Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Paediatrics 1983;72:317-21.
5. Balmer SE, Wharton BA. Diet and faecal flora in the newborn: Breast milk and infant formula. Arch Dis Child 1989;64:1672-7.
6. Benno Y, Sawada K, Mitsuoka T. The intestinal microflora in infants: Composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 1984;28:975-86.
7. Chierici R, Sawatzki G, Thurl S, Tovar K, Vigi V. Experimental milk formulae with reduced protein content and desialylated milk proteins: Influence on the faecal flora and the growth of term newborn infants. Acta Paediatr 1997;86:557-63.
8. Kleessen B, Bunke H, Tovar K, Noack J, Sawatzki G. Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants. Acta Paediatr 1995;84:1347-56.
9. Mata LJ, Urutia JJ. Intestinal colonization of breast-fed children in rural area of low socioeconomic level. Ann NY Acad Sci 1971;176:93-109.
10. Stark PL, Lee A. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol 1982;15:189-203.
11. Yuhara T, Isojima S, Tsuchiaya F, Mitsuoka T. On the intestinal flora of bottle-fed infant. Bifidobact Microflora 1983;2:33-9.
12. Bell MJ. Changes in the incidence of necrotizing enterocolitis associated with variation of the gastrointestinal microflora in neonates. Am J Surg 1979;138:529-38.
13. Blakey JL, Lubitz L, Capbell NT, Gillan GL, Bishop RF, Barnes GL. Enteric colonization in sporadic neonatal narcotizing enterocolitis. J Pediatr Gastroenterol Nutr 1985;4:591-5.
14. Grönlind M-M, Lehtonen O-P, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: Permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 1999;28:19-25.
15. Kitajima H, Sumida Y, Tanaka R, Takayama N, Fujimura M. Early administration of Bifidobacterium breve to preterm infants: Randomized controlled trial. Arch Dis Child 1997;76:F101-7.
16. Kliegman RM, Fanaroff AA. Nectrofizing enterocolitis. N Engl J Med 1984;310:1093-103.
17. Mutai M, Tanaka R. Ecology of Bifidobacterium in the human intestinal flora. Bifidobact Microflora 1987;6:33-41.
18. Bouhnik Y, Flourie B, D'Agay-Abensour L, Pochart P, Gramet G, Durand M, Rambaud J-C. Administration of transglacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr 1997;127:444-8.
19. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 1995;125:1401-12.
20. Hidaka H, Eida T, Takizawa T, Tokunaga T, Tashiro Y. Effect of fructooligosacchrides on intestinal flora and human health. Bifidobact Microflora 1986;5:37-50.
21. Kawase K, Suzuki T, Kiyosawa I, Okonogi S, Kawashima T, Kuboyama M. Effects of composition of infant formulas on the intestinal microflora of infants. Bifidobact Microflora 1983;2:25-31.
22. Morishita Y, Sawairi Y, Ozawa O, Ohtsuka K. Effect of 4′-galactosyllactose in diet and water on the cecal fermentation in mice. Bifidus 1995;9:1-4 (in Japanese).
23. Ohkusa T, Ozaki Y, Sato C, Mikuni K, Ikeda H. Long-term ingestion of lactosucrose increases Bifidobacterium sp. in human fecal flora. Digestion 1995;56:415-20.
24. Kullen MJ, Khil J, Gallaher FF, Brady LJ. Carbohydrate source and bifidobacteria influence the growth of Clostridium perfringens in vivo and in vitro. Nutr Res 1998;18:1889-97.
25. Ohtsuka K, Benno Y, Endo K, Ueda H, Ozawa O, Uchida T, Mitsuoka T. Effect of 4′galactosyllactose intake on human fecal microflora. Bifidus 1989;2:143-9 (in Japanese).
26. Morishita Y, Konishi Y. Effect of high dietary cellulose on the large intestinal microflora and short-chain fatty acids in rats. Lett Appl Microbiol 1994;19:433-5.
27. Morishita Y, Ohtsuka K, Sawairi Y, Ozawa O. Effect of 4′-galactosyllactose on the cecal microflora and short-chain fatty acids in rats. Bifidus 1993;7:21-7 (in Japanese).
28. Suzuki M, Sato S, Oowada B, Ozaki A, Mizutani T, Morishita Y. The effect of dietary galactooligosaccharide on the formation of infant intestinal microflora in gnotobiotic mouse models. J Intest Microbiol 1999;12:81-8 (in Japanese).
29. Mizutani T, Yamamoto T, Ozaki A, Oowada T, Mitsuoka T. Spontaneous polyposis in the small intestine of germ-free and conventionalized BALB/c mice. Cancer Lett 1984;25:19-23.
30. Morishita Y, Nagasawa K, Nakano N, Shiromizu K. Bacterial overgrowth in the jejunum of ICR mice and Wistar rats orally administered with a single dose of fuzarenon-X, a trichothecene micotoxin. J Appl Bacteriol 1989;66:263-70.
31. Mitsuoka T, Ohno K, Benno Y, Suzuki K, Namba K. Die Faekalflora bei Menschen. IV. Mitteilung: Vergleich des neu entwickelten Verfahrens mit dem bisheringen üblichen Verfahren zur Darmfloraanalyze. Zbl Bakteriol Hyg Abt I Orig A 1976;234:219-33.
32. Wang X, Gibson GR. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growth in the human large intestine. J Appl Bacteriol 1993;75:373-80.
33. Hara H, Shou-Tou Li, Sasaki M, Maruyama T, Terada A, Ogata Y, Fujita K, Ishigami H, Hara K, Fujimori I, Mitsuoka T. Effective dose of lactosucrose on fecal flora and fecal metabolites of humans. Bifidobact Microflora 1994;13:51-63.
34. Catala I, Butel M J, Bensaada M, Popot F, Tessedre A, Rimbault A, Szylit O. Oligofructose contributes to the protective role of bifidobacteria in experimental narcotizing enterocolitis in quails. J Med Microbiol 1999;48:89-94.
35. Caplan MS, Miller-Catchpole R, Kaup S, Russell T, Lickerman M, Amer M, Xiao Y, Thomson R Jr. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in neonatal rat model. Gastroenterology 1999;117:577-83.